Metastases to the ovary are relatively common with a documented incidence of 5-30% of all malignant ovarian masses.
These may be incorrectly grouped under Krukenberg tumors, which are signet cell containing tumors that form only 30-40% of all ovarian metastases.
There is often a known primary at presentation. Patients may present with abdominal symptoms such as pain or palpable pelvic mass. Hormonal overactivity can also be occasionally seen due to hyperplasia of ovarian stroma.
These are large lobulated tumors with areas of hemorrhage and necrosis. The contour of the ovary is usually preserved. Lesions are commonly bilateral.
They usually spread by haematogenous route, lymphatic route or by the direct spread. There are usually surface deposits of tumors with invasion of the stroma.
Metastases to the ovary commonly arise from the gastrointestinal tract, breast, lungs and contralateral ovaries. Other rare primaries include endometrium, melanoma, pancreas, carcinoid, leukemia 6, renal cell carcinoma 7, hepatocellular carcinoma 8, gallbladder carcinoma 9, bladder transitional cell carcinoma 10, neuroblastoma 11, and reticuloendothelial tumors 12.
These are mixed echogenicity tumors with vascularity of solid component on Doppler.
Soft tissue density with areas of cystic necrosis. On contrast, solid components demonstrate inhomogeneous enhancement.
- T1: iso to hypointense with variable enhancement on contrast
- T2: heterogenous signal of the solid component with hyperintensity of the cystic component
Treatment and prognosis
Treatment involves radical tumor-reductive surgery. The prognosis for metastases is very poor with a 1-year rate of survival less than 10%.
Imaging differential considerations include:
- 1. Lee SJ, Bae JH, Lee AW et-al. Clinical characteristics of metastatic tumors to the ovaries. J. Korean Med. Sci. 01;24 (1): 114-9. doi:10.3346/jkms.2009.24.1.114 - Free text at pubmed - Pubmed citation
- 2. Yada-Hashimoto N, Yamamoto T, Kamiura S et-al. Metastatic ovarian tumors: a review of 64 cases. Gynecol. Oncol. 2003;89 (2): 314-7. Pubmed citation
- 3. Hricak H. Diagnostic Imaging. AMIRSYS. (2007) ISBN:1416033386. Read it at Google Books - Find it at Amazon
- 4. Khunamornpong S, Suprasert P, Chiangmai WN et-al. Metastatic tumors to the ovaries: a study of 170 cases in northern Thailand. Int. J. Gynecol. Cancer. 2006;16 Suppl 1 (S1): 132-8. Int. J. Gynecol. Cancer (full text) - doi:10.1111/j.1525-1438.2006.00302.x - Pubmed citation
- 5. De Waal YR, Thomas CM, Oei AL et-al. Secondary ovarian malignancies: frequency, origin, and characteristics. Int. J. Gynecol. Cancer. 2009;19 (7): 1160-5. doi:10.1111/IGC.0b013e3181b33cce - Pubmed citation
- 6. Pais RC, Kim TH, Zwiren GT, Ragab AH. Ovarian tumors in relapsing acute lymphoblastic leukemia: a review of 23 cases. (1991) Journal of pediatric surgery. 26 (1): 70-4. Pubmed
- 7. Guney S, Guney N, Ozcan D, et al. Ovarian metastasis of a primary renal cell carcinoma: case report and review of literature. (2010) European journal of gynaecological oncology. 31 (3): 339-41. Pubmed
- 8. Lee JM, Park KM, Lee SY,et al. Metastasis of hepatocellular carcinoma to the ovary: a case report and review of the literature. (2011) Gut and liver. 5 (4): 543-7. doi:10.5009/gnl.2011.5.4.543 - Pubmed
- 9. Carlomagno C, Insabato L, Bifulco G, et al. Ovarian metastasis following gallbladder carcinoma: a case report. (2010) European journal of gynaecological oncology. 31 (2): 219-21. Pubmed
- 10. Ishii Y, Itoh N, Takahashi A, zt al. Bladder cancer discovered by ovarian metastasis: cytokeratin expression is useful when making differential diagnosis. (2005) International journal of urology : official journal of the Japanese Urological Association. 12 (1): 104-7. doi:10.1111/j.1442-2042.2004.00972.x - Pubmed
- 11. Somjee S, Kurkure PA, Chinoy RF, et al. Metastatic ovarian neuroblastoma: a case report. (1999) Pediatric hematology and oncology. 16 (5): 459-62. doi:10.1080/088800199277029 - Pubmed
- 12. Wolfgang F. Dahnert. Radiology Review Manual. (2011) ISBN: 9781496360694